{
	"kj8twh4aText": "Brintellix<span class=\"_ _0\"></span>® significant<span class=\"_ _1\"></span>ly impro<span class=\"_ _0\"></span>ved anxiet<span class=\"_ _1\"></span>y <br><span class=\"ls23 ws2e\">s<span class=\"_ _1\"></span>ymptoms in patie<span class=\"_ _0\"></span>nt<span class=\"_ _1\"></span>s wit<span class=\"_ _1\"></span>h MDD<span class=\"_ _0\"></span>*<span class=\"fs2 ls0 v1\">1</span></span>",
	"kj8twh4bText": "Study Design",
	"kj8twh4cText": "Mean change from baseline",
	"kj8twh4dText": "Change in HAM-A total scor<span class=\"_ _0\"></span>e in adult patients with MDD<span class=\"fs13 v5\">1</span>",
	"kj8twh4eText": "T<span class=\"_ _2\"></span>reatment week",
	"kj8twh4fText": "Placebo (n=101)",
	"kj8twh4gText": "*As measured by HAM-A; **p&lt;0.05; ***p&lt;0.01; <span class=\"fsd ws1c v2\">†</span>p&lt;0.001 vs.<span class=\"_ _0\"></span> placebo.<br>Mean baseline HAM-A score was 22.2, representing a substantial level of anxiety. Venlafaxine was included as an active reference for study validation, not for\ncomparison of effect size.&nbsp;<br><span class=\"fsd ws1c\">‡</span><span class=\"v6\">Brintellix® d does not exhibit many of the side effects typical of SSRIs and SNRIs including sexual dysfunction and weight gain.</span><span class=\"fsd ws1c\">2-5</span><span class=\"v6\"> Side effects associated with&nbsp; Brintellix® <br>LOCF, last observation carried forward.<br></span>",
	"kj8twh4hText": "Brintellix® 5 mg <br>(n=101)",
	"kj8twh4iText": "Brintellix® 10 mg <br>(n=94)",
	"kj8twh4jText": "V<span class=\"_ _0\"></span>enlafaxine 225 mg <br>(n=105) <br><span class=\"ws58\"> (active <span class=\"_ _16\"> </span>r<span class=\"_ _0\"></span>eference)</span>",
	"kj8twh4kText": "LOCF  ",
	"kj8twh4lText": "endpoint",
	"Brintellix_50e17a59a4": "Text",
	"Brintellix_505c9a634c": "Text",
	"Brintellix_506ef24c26": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); \">\n<font style=\"font-size: 25px;\">References</font>\n</span>",
	"Brintellix_50df36e05a": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(84, 122, 129); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>1.</b> Alvarez E et al. Int J Neuropsychopharmacol 2012;15:589-600.\n</font>\n</span>",
	"Brintellix_504caf893c": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(84, 122, 129); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>2.</b> Brintellix® Summary of Product Characteristics. 2021. \n</font>\n</span>",
	"Brintellix_502c006883": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(84, 122, 129); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>3.</b> Cipralex® Summary of Product Characteristics. 2020.\n</font>\n</span>",
	"Brintellix_50d0b1d33e": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(84, 122, 129); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>4.</b> Effexor® Summary of Product Characteristics. 2020.\n</font>\n</span>",
	"Brintellix_50c98e5d0c": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(84, 122, 129); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>5.</b> Seroxat® Summary of Product Characteristics. 2019.\n</font>\n</span>",
	"Brintellix_500d4def09": "Text",
	"Brintellix_5082fba1b7": "Text",
	"Brintellix_505ee21f62": "Text",
	"Brintellix_50a646f161": "Text",
	"Brintellix_50d0158e6a": "Text",
	"Brintellix_5005b92ca9": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;background-color: #e5f0f2;box-sizing: border-box;color: #4d7f86;\">\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 4.5px 22px;line-height:1.1;background-color: #e5f0f2;\">Emotional<br>Blunting</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 13px 30px 11px;line-height:1.1;background-color: #e5f0f2;color: #fff;background: rgb(233,90,0);background: linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);background: -webkit-linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);\">High anxiety</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 13px 45px 11px;line-height:1.1;background-color: #e5f0f2;\">Trauma</div>\n</div>",
	"Brintellix_50d3eeed5e": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;background-color: #e5f0f2;box-sizing: border-box;color: #4d7f86;\">\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 4px 30px 2px;line-height:1.3;background-color: #e5f0f2;color: #fff;background: rgb(233,90,0);background: linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);background: -webkit-linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);\">HAM-A &gt; 20</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 4px 21px 2px;line-height:1.3;background-color: #e5f0f2;\">Comorbid GAD</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 4px 8px 2px;line-height:1.3;background-color: #e5f0f2;\">Real-World Data (REVIDA)</div>\n</div>"
}
